Related Experiment Video
Updated: Mar 15, 2026

Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae
Published on: February 24, 2023
Kawasaki disease associated with Mycoplasma pneumoniae
Yunjia Tang1, Wenhua Yan1, Ling Sun1
1Department of Cardiology, Children's Hospital of Soochow University, Suzhou, China.
Background:
Kawasaki disease (KD) is an illness of unknown etiology that mostly occurs in children under 5 years of age and is the leading cause of acquired heart disease all over the world. Mycoplasma pneumoniae (MP) was one of the likely causative agents of KD. However, the etiologic effect of MP in KD has not been fully recognized.
Methods:
We prospectively analyzed the clinical records of 450 patients with KD hospitalized in Children's Hospital of Soochow University from 2012 to 2014. Using medical records, we retrospectively identified patients with low respiratory tract infection (non-KD group).
Results:
Of the 450 KD patients, MP was positive in 62 (13.8 %). The median age of the MP + KD+ group was significantly older than the MP-KD+ group (25 vs 14.5 months, P < 0.01). MP + KD+ group had higher levels of ESR, N% and CRP than the MP-KD+ group. MP + KD+ group were more frequent in respiratory disorders than MP-KD+ group with a P < 0.05. No statistical difference of non-responders or coronary artery lesion was found between the groups.
Conclusions:
MP infections are found in an important proportion of the KD patients (13.8 % in our series). MP infection tended to occur in older populations and with a higher rate of respiratory tract involvement in patients with KD. No statistical difference of non-responders or coronary artery lesion was found between the MP+ and MP- KD patients.
Insights
Mycoplasma pneumoniae (MP) infections are present in 13.8% of Kawasaki disease (KD) patients, often affecting older children with respiratory issues. This study found no link between MP infection and non-response or coronary artery lesions in KD patients.
Area of Science:
- Pediatrics
- Infectious Diseases
- Cardiology
Background:
- Kawasaki disease (KD) is a leading cause of acquired heart disease in children, with an unknown etiology.
- Mycoplasma pneumoniae (MP) is a suspected, but not fully recognized, causative agent of KD.
- Understanding potential infectious triggers like MP is crucial for KD management.
Purpose of the Study:
- To investigate the prevalence and clinical characteristics of Mycoplasma pneumoniae (MP) infection in children diagnosed with Kawasaki disease (KD).
- To determine if MP infection is associated with specific clinical presentations, laboratory findings, or outcomes in KD patients.
Main Methods:
- Prospective analysis of clinical records for 450 KD patients hospitalized between 2012 and 2014.
- Retrospective identification of patients with lower respiratory tract infections (non-KD group) for comparison.
- Evaluation of MP positivity, patient demographics, inflammatory markers (ESR, CRP), and clinical outcomes (response to treatment, coronary artery lesions).
Main Results:
- MP infection was detected in 13.8% (62/450) of KD patients.
- MP-positive KD patients were significantly older and exhibited higher rates of respiratory disorders compared to MP-negative KD patients.
- No significant differences were observed in treatment non-response or coronary artery lesion development between MP-positive and MP-negative KD groups.
Conclusions:
- Mycoplasma pneumoniae (MP) infections are identified in a notable proportion of Kawasaki disease (KD) cases.
- MP infection in KD is associated with older age and increased respiratory involvement.
- MP infection does not appear to influence treatment responsiveness or the risk of coronary artery lesions in KD patients.
Related Concept Videos
Pneumonia II: Pathophysiology
Myocarditis I: Introduction
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Rheumatic Heart Disease I: Introduction
